Marc de Garidel, the chairman and chief executive officer of Ipsen SA, has been named chair of the governing board of the Innovative Medicines Initiative, a public-private partnership between the European Union and Efpia, the European pharmaceutical industry association. Mr de Garidel worked for Eli Lilly and Company and Amgen Inc before joining Ipsen in 2010. He is currently also vice president of Efpia.
The IMI announced the appointment on 24 March 2015.
Copyright 2015 Evernow Publishing Ltd